Center for the Study of Drug Development Records
Scope and Contents
- Majority of material found within 1986 -- 2001
- 1984 -- 2017
Conditions Governing Use
Immediate Source of Acquisition
This collection is arranged in seven series: Annual reports; Conference proceedings; Course announcements; Reprints and research publications; Promotional materials; Impact and Outlook reports; and R&D Management Reports.
1.2 Linear Feet (1 box)
1 Digital Object(s)
Language of Materials
Biographical / Historical
Since the creation of the Center for the Study of Drug Development in 1976, the Center has done research in several fields surrounding the development of drugs. The TCSDD was the first organization to complete a comprehensive review of the cost of making a new drug and putting it on the market: $54 million in 1979, which had risen to $2.6 billion by 2014. These studies came under fire in 2016, when the TCSDD and their donors were the focus of protests as part of a global action campaign against high pharmaceutical prices led by ACT UP. Protesters demanded to know the names of donors funding the cost evaluation research conducted by Joseph DiMasi, but TSCDD director Kenneth Kaitin confirmed that no direct funding from any pharmaceutical companies was used in the drug development evaluations, and declined to release donor names, as it was against Center policy. The TCSDD continues to work in several fields related to the development of new drugs, including cost evaluation, biotechnology comparison, FDA policy review, drug effectiveness, regulation timeframes, drug withdrawals, and more.